Objectives To describe parotid gland (PG) saliva organic and inorganic composition and
flow rate changes, after curative intensity‐modulated radiotherapy (IMRT) for head and neck …

OBJECTIVES: Factors influencing xerostomia during intensity-modulated radiation therapy
(IMRT) were assessed. METHODS: A 6-week study of 32 head and neck cancer (HNC) …

PURPOSE: To describe the dose–response relationships for the different measures of
salivary gland recovery following radical radiotherapy for locally advanced head and neck …

Purpose: To investigate the strength of correlation between measured saliva flow rates and
various toxicity endpoints commonly used in head and neck cancer (HNC) treatment …

OBJECTIVE: We investigated salivary function using quantitative scintigraphy and sought to
identify functional correlations between parotid dose and quality of life (QoL) for head and …

Radiotherapy (RT) for head and neck cancers causes permanent salivary gland dysfunction
(SGD) and xerostomia. We have previously demonstrated the effectiveness of parotid …

Purpose: Xerostomia is a severe complication after radiotherapy for oropharyngeal cancer,
as the salivary glands are in close proximity with the primary tumor. Intensity-modulated …

BACKGROUND AND PURPOSE: To investigate the salivary gland function following
intensity modulated radiotherapy (IMRT) for head and neck cancer. PATIENTS AND …

Purpose: To assess long-term xerostomia in patients receiving parotid-sparing radiation
therapy (RT) for head-and-neck cancer, and to find the patient and therapy-related factors …

Recent efforts to reduce xerostomia associated with irradiation (RT) of head and neck
cancer include the use of conformal and intensity-modulated RT (IMRT) to partly spare the …